Your session is about to expire
What is Lenalidomide
Approved as Treatment by the FDA
Lenalidomide, also known as Revlimid, is approved by the FDA for 15 uses which include Multiple Myeloma (MM) and Transfusion-dependent Anemia .Effectiveness
When to interrupt dosage
The suggested dose of Lenalidomide relies upon the determined condition, including Mantle Cell Lymphoma, Relapsed and/or Refractory Lymphoma and Refractory Diffuse Large B Cell Lymphoma (DLBCL). The magnitude of dosage is contingent upon the technique of delivery (e.g. Capsule - Oral or Oral) detailed in the table hereunder.Warnings
Lenalidomide has one contraindication, so it should not be taken when you have any of the conditions in the following table.Lenalidomide ContraindicationsLenalidomide Novel Uses: Which Conditions Have a Clinical Trial Featuring Lenalidomide?
426 active trials are presently being conducted to evaluate the potential of Lenalidomide in treating previously treated, Relapsed and/or Refractory Lymphoma and Multiple Myeloma.Lenalidomide Reviews: What are patients saying about Lenalidomide?
Patient Q&A Section about lenalidomide
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.How long can you stay on lenalidomide?
"The average amount of time that patients took lenalidomide was 21 months, with 25% of patients taking it for less than 11 months and 25% taking it for more than 31 months. The treatment was stopped for 64.7% (n = 90) of the patients when the analysis was done."
What are side effects of lenalidomide?
"If you experience any of the following side effects, tell your doctor or pharmacist immediately: diarrhea, stomach/abdominal pain, nausea/vomiting, loss of appetite, constipation, dizziness, dry skin, dry mouth, or trouble sleeping. These side effects may be indicative of a serious condition."
How long can you take lenalidomide?
"The average length of time a patient stayed on lenalidomide maintenance was 21 months, with 25% of patients receiving less than 11 months of maintenance and 25% receiving longer than 31 months. The treatment had been discontinued in 64.7% of patients by the time the analysis was performed."
What is the function of lenalidomide?
"Lenalidomide is a drug used to treat anemia (low red blood cell count) in patients with myelodysplastic syndrome (MDS), a condition in which the bone marrow doesn't produce enough healthy blood cells. People with MDS may require blood transfusions to make up for the lack of healthy red blood cells."
Is lenalidomide a chemotherapy?
"Myeloma is a cancer of the blood, and lenalidomide is a treatment for it. Myelodysplastic syndromes are blood disorders, and lenalidomide is a treatment for them. Clinical trials are ongoing for the use of lenalidomide in other types of cancer."
What type of drug is lenalidomide?
"Lenalidomide is a drug used to treat cancer, also known by its brand name Revlimid. It is a treatment for myeloma, a type of blood cancer, as well as for blood disorders called myelodysplastic syndromes. You may also receive lenalidomide as part of clinical trials for other types of cancer. If you have myeloma, you might be treated with lenalidomide in combination with a steroid drug called dexamethasone."